Patent · US Active

Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate

US7829723B2 · kind B2 · utility

0Cited by

2References

10Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Todd Blythe · Georgetown, US
Petinka Vlahova · West Lafayette, US

Key dates

Filing date	Feb 4, 2009
Grant date	Nov 9, 2010
Priority date	—
Expiry date	Feb 4, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)phenyl)ethylcarbamate, pharmaceutical compositions thereof, processes to prepare therein, and uses therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.